ETFs Zai Lab Limited Hong Kong S.E.

9688

KYG9887T1168

Name	YTD change	Weight	AuM
UBS MSCI ACWI CLIMATE PARIS ALIGNED UCITS ETF ACC - USD	+12.13%	-	122 M€
DIMENSIONAL WORLD EQUITY ETF - USD	+11.99%	-	1,674 M€
CI GROWTH ASSET ALLOCATION ETF -CAD	+9.16%	-	67 M€
UNLIMITED HFND MULTI-STRATEGY RETURN TRACKER ETF - USD	+4.28%	-	37 M€
DIMENSIONAL EMERGING MARKETS CORE EQUITY 2 ETF - USD	+12.52%	-	9,273 M€
ISHARES MSCI CHINA SMALL-CAP ETF - USD	-20.09%	1.01%	67 M€
UBS SOLACTIVE CHINA TECHNOLOGY UCITS ETF A-ACC - USD	-23.53%	0.49%	257 M€
UBS SOLACTIVE CHINA TECHNOLOGY UCITS ETF A-ACC - EUR HEDGED	-27.29%	0.26%	127 M€
STATE STREET SPDR S&P EMERGING MARKETS SMALL CAP ETF - USD	+3.67%	0.26%	701 M€
HSBC MSCI EMERGING MARKETS SMALL CAP ESG UCITS ETF USD (ACC) - USD	+13.75%	0.18%	61 M€
ISHARES MSCI AC FAREAST EXJPN SC ETF$DIS	-.--%	0.18%	74 M€
ISHARES MSCI AC FAR EAST EX-JAPAN SMALL CAP UCITS ETF - USD	+11.07%	0.18%	74 M€
WISDOMTREE CHINA EX-STATE-OWNED ENTERPRISES FUND - USD	-19.62%	0.12%	500 M€
FRANKLIN FTSE CHINA UCITS ETF - ACC - USD	-14.55%	0.12%	1,754 M€
ISHARES MSCI EMERGING MARKETS SMALL-CAP ETF - USD	+5.52%	0.12%	380 M€
STATE STREET SPDR MSCI EMERGING MARKETS SMALL CAP UCITS ETF - USD	+10.57%	0.12%	611 M€
ISHARES MSCI EM SMALL CAP UCITS ETF - USD	+4.59%	0.11%	337 M€
XTRACKERS EMERGING MARKETS NET ZERO PATHWAY PARIS ALIGNED UCITS ETF 1C - USD	+25.23%	0.08%	17 M€
FRANKLIN FTSE CHINA ETF - USD	-18.40%	0.07%	338 M€
XTRACKERS MSCI GLOBAL SDG 3 GOOD HEALTH UCITS ETF 1C - USD	+13.32%	0.06%	28 M€
AMUNDI GLOBAL MEMORY CHIPS UCITS ETF ACC - USD	+7.11%	0.05%	320 M€
STATE STREET SPDR S&P CHINA ETF - USD	-16.11%	0.04%	476 M€
VANGUARD FTSE ASIA EX-JAPAN SHARES INDEX ETF - AUD	+6.10%	0.04%	535 M€
XTRACKERS MSCI GLOBAL SDGS UCITS ETF 1C - USD	+7.46%	0.04%	8 M€
FRANKLIN FTSE EMERGING MARKETS UCITS ETF - USD	-.--%	0.04%	11 M€
STATE STREET SPDR MSCI EMERGING MARKETS UCITS ETF - USD	+19.49%	0.03%	2,215 M€
SCHWAB EMERGING MARKETS EQUITY ETF - USD	+6.75%	0.03%	12,827 M€
XTRACKERS EMERGING MARKETS CARBON REDUCTION AND CLIMATE IMPROVERS ETF - USD	+8.79%	0.03%	61 M€
WISDOMTREE EMERGING MARKETS EX-STATE-OWNED ENTERPRISES UCITS ETF ACC - USD	+15.24%	0.03%	23 M€
VANGUARD ESG EMERGING MARKETS ALL CAP UCITS ETF ACC - USD	+14.39%	0.03%	117 M€
HSBC EMERGING MARKET SUSTAINABLE EQUITY UCITS ETF - USD	+16.75%	0.03%	199 M€
AMUNDI PRIME EMERGING MARKETS - UCITS ETF DR (C) - USD	+16.97%	0.03%	974 M€
ISHARES CORE MSCI EMERGING MARKETS IMI ETF - JPY	+11.20%	0.02%	189 M€
ISHARES CURRENCY HEDGED MSCI EMERGING MARKETS ETF - USD	+12.69%	0.02%	293 M€
DESJARDINS EMERGING MARKETS EQUITY INDEX ETF - CAD	+13.24%	0.02%	677 M€

Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.

Employees

1,784

Sector

Pharmaceuticals

Calendar

11-05 Earnings release - Q3 2026

More about the company